[HTML][HTML] Advancements in neoadjuvant immune checkpoint inhibitor therapy for locally advanced head and neck squamous Carcinoma: A narrative review
J Li, Z Luo, S Jiang, J Li - International Immunopharmacology, 2024 - Elsevier
The prevalent treatment paradigm for locally advanced head and neck squamous carcinoma
(HNSCC) typically entails surgery followed by adjuvant radiotherapy and chemotherapy …
(HNSCC) typically entails surgery followed by adjuvant radiotherapy and chemotherapy …
Association between plasma circulating tumor DNA and the prognosis of esophageal cancer patients: a meta-analysis
H Zhang, T Jin, Y Peng, S Luan, X Li… - … Journal of Surgery, 2024 - journals.lww.com
Background: The application of liquid biopsy analysis utilizing circulating tumor DNA
(ctDNA) has gained prominence as a biomarker in specific cancer types. Nevertheless, the …
(ctDNA) has gained prominence as a biomarker in specific cancer types. Nevertheless, the …
IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells
X Li, X Zhao, X Su, J Wen, S Yang, Y Qin, S Yan… - Archives of Biochemistry …, 2024 - Elsevier
Chemoresistance is one of the major hindrances to many cancer therapies, including
esophageal squamous cell carcinoma (ESCC). Ferroptosis, a new programmed cell death …
esophageal squamous cell carcinoma (ESCC). Ferroptosis, a new programmed cell death …